研究单位：[1]BEIJING TONGREN HOSPITAL,CMU,Beijing,China[2]Chengdu Kanghong Biotech Co., Ltd.[3]Baoji People'S Hospital,Baoji,China[4]Beijing Aier-Intech Eye Hospital,Beijing,China[5]Zhongshan Ophthalmic Center, Sun Yay-Sen University,Zhongshan,China[6]Eye Hospital, China Academy of Chinese Medical Sciences,Beijing,China[7]Peking Union Medical College Hospital,Beijing,China[8]Peking University Third Hospital,Beijing,China[9]The 306Th Hospital of Pla,Beijing,China[10]Xuanwu Hospital Capital Medical University,Beijing,China[11]Sichuan Provincial People's Hospital,Chengdu,China[12]The Second Affiliated Hospital of Chongqing Medical University,Chongqing,China[13]The First Affiliated Hospital of Dalian Medical University,Dalian,China[14]The third people's Hospital of Dalian,Dalian,China[15]The Second Affiliated Hospital of Guangzhou Medical University,Guangzhou,China[16]The Affiliated Hospital of Guizhou Medical University,Guiyang,China[17]The Second Affiliated Hospital of ZhejiangUniversity School of Medicine,Hangzhou,China[18]Anhui Provincial Hospital,Hefei,China[19]JOINT SHANTOU INTERNATIONAL EYE CENTER of Shantou University and The Chinese University of Hong Kong,Hongkong,China[20]Shandong Eye Hospital,Jilan,China[21]Shandong Provincal Hospital,Jilan,China[22]The Second Hospital of Jilin University,Jiling,China[23]Kashgar First People's Hospital,Kashi,China[24]Lanzhou University Second Hospital,Lanzhou,China[25]Central Hospital of Mudanjiang Forestry,Mudanjiang,China[26]Jiangsu Province Hospital of CTM,Nanjing,China[27]The People'S Hospital of Guangxi Zhuang Autonomous Region,Nanning,China[28]Ningbo Eye Hospital,Ningbo,China[29]Ningxia People'S Hospital,Ningxia,China[30]Pingdingshan People'S Hospital No.1,Pingdingshan,China[31]The First Hospital of Qiqihar,Qiqihar,China[32]Rui Jin Hospital Shanghai Jiao Tong University School of Medicine,Shanghai,China[33]Shanghai Baoshan Hospital of Integrate Traditional Chinese and Western Medicine,Shanghai,China[34]Shanghai General Hospital,Shanghai,China[35]Shanghai Tongji Hospital,Shanghai,China[36]Shenyang the Fourth Hospital of People,Shenyang,China[37]The Fourth Affiliated Hospital of China Medical University,Shenyang,China[38]Peking University Shenzhen Hospital,Shenzhen,China[39]Shenzhen Eye Hospital,Shenzhen,China[40]The Second Hospital of Hebei Medical University,Shijiazhuang,China[41]Shanxi Eye Hospital,Taiyuan,China[42]Tianjin Medical University Eye Hospital,Tianjin,China[43]Wuhan General Hospital of Pla,Wuhan,China[44]No.474 Hospital of Pla,Wulumuqi,China[45]Wuxi NO.2 People's Hospital,Wuxi,China[46]Tangdu Hospital,Xi'an,China[47]Xi'An No.4 Hospitla,Xi'an,China[48]Xijing Hospital,Xian,China[49]Hebeisheng Eye Hospital,Xingtai,China[50]The First People's Hospital of Xuzhou,Xuzhou,China
研究目的：
This is a post-marketing drug safety monitoring study in a prospective manner, and data collection will be performed in a registration-follow-up manner. Safety information about patients who have received intravitreal injection of Conbercept Ophthalmic Injection in medical institutions involved in the study during research will be actively monitored without intervening in diagnosis and treatment. All patients enrolled will be followed up for one year.
